View
About the views

Guided View. New to dividends? Yields, ex-dividend dates, payout ratios, DRIP: we explain every term as you browse, in plain English. Same data, with the help built in.

Expert View. You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Theme
Dividendly Independent dividend research

← Back to declarations

SNPHY Santen Pharmaceutical Co., Ltd. — dividend yield, history & ex-dividend dates

Other OTC· Semi-Annual dividend· Common Stock· ADR · Healthcare / Drug Manufacturers - General

$10.78 ▼ $-0.23(-2.09%) as of Oct 30, 2026 06:20 UTC
Sponsored Advanced charts & data →

Santen Pharmaceutical Co., Ltd. is a global enterprise dedicated to the research, development, manufacturing, and distribution of pharmaceuticals and medical devices, with operations spanning Japan and international markets. The company maintains a significant pipeline and array of products focused on ophthalmic conditions. For glaucoma and ocular hypertension, their drug candidates encompass DE-111, currently undergoing Phase III clinical evaluation; DE-117, which is available in Japan; DE-126, now in Phase IIb trials; DE-128, being developed for European markets and also in Phase II/III trials within the United States; and DE-130A, another compound advancing through Phase III clinical trials. Santen's development efforts also extend to treatments for other eye ailments: DE-114A for allergic conjunctivitis, DE-076C to address vernal keratoconjunctivitis, and DE-109, a therapy for uveitis that is in Phase III trials. Furthermore, their initiatives against myopia include DE-127, which is simultaneously in Phase II/III clinical trials in Japan and Phase III across Asia, alongside STN1013400, currently in its initial Phase I clinical trials for the same condition. They also offer DE-089C, a treatment for dry eye that has successfully completed its Phase III clinical trials. Beyond prescription medications, Santen also supplies a selection of over-the-counter pharmaceutical products. The corporation, founded in Osaka, Japan, in 1890, was initially known as Santendo Pharmaceutical Co., Ltd. before formally adopting its current name, Santen Pharmaceutical Co., Ltd., in 1958.

Dividend Snapshot

StatusReduced
Last Dividend$0.1098Pays Nov 30, 2026
Forward Annual$0.23Regular dividends paid over the last 12 months
FrequencySemi-Annual
Last Ex-DateSep 29, 2026The most recent ex-dividend date that has already passed.
1-Yr Growth15.0%Annual totals, 2024–2025
10-Yr Growth-3.0%Annual totals, 2015–2025

Research Scores

Scores describe this security's published financial data on a 0–100 scale using the formulas on our methodology pages. They are the same for every reader, are not a probability or a forecast, and are not a recommendation. Past dividend growth does not guarantee future increases. Report a data error.

Dividend Safety Score

92/100

Very strong indicators

Complete data

Dividend Growth Score

41/100

Moderate growth record

Most data available

Dividend Value Score

Not Rated

only 40% of the inputs available (60% needed)

DividendRank

64/100

Upper middle of the scale

Partial data

How the Dividend Safety Score is built for SNPHY
InputValuePointsWeight
Earnings payout ratioEarnings payout ratio 32% (TTM to Jun 30, 2026) 100 20%
FCF payout ratioFCF payout ratio 30% (TTM to Jun 30, 2026) 100 25%
Net debt / EBITDANet cash (TTM to Jun 30, 2026) 100 15%
Interest coverageInterest coverage 17.7x (TTM to Jun 30, 2026) 100 10%
Dividend record15 years of uninterrupted regular payments 77 20%
Earnings stabilityNet income positive in 4 of the last 5 fiscal years (FY2022–FY2026) 70 10%

Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.

How the Dividend Growth Score is built for SNPHY
InputValuePointsWeight
5-year dividend growth5-year dividend CAGR -1.0% (2020–2025) 20 25%
Consecutive annual increases0 consecutive annual increases (through 2025) 10 20%
Payout headroomHeadroom from the earnings payout ratio 32% (TTM to Jun 30, 2026) 100 20%
Earnings per share growth (3 years)N/A (not used) N/A 15%
Revenue growth (3 years)Revenue CAGR 3.5% (FY2023–FY2026) 70 10%
10-year dividend growth10-year dividend CAGR -3.0% (2015–2025) 10 10%

Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.

Key Metrics

Current Yield

2.11%

At the Oct 30, 2026 price

The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.

Annualized Dividend

$0.2270

The latest declared regular dividend scaled to a full year by how often it's paid (for semi-annual payers, the latest two payments), adjusted for stock splits. A $0.25 quarterly dividend annualizes to $1.00. Special dividends are excluded.

Frequency

S Semi-Annual

How often the dividend is paid, read from the dates of recent payments: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.

RSI (14)

46

As of Oct 30, 2026

Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.

52-Week Range

$9.62 – $13.90

Closes through Oct 23, 2026

The lowest and highest price over the past year, showing where today's price sits in its recent range.

Payout Ratio (TTM)

31.76%

12 months to Jun 30, 2026 (Q1 FY2027)

The share of earnings paid out as dividends over the trailing twelve months (TTM): dividends paid divided by net income across the company's four most recent reported quarters, dated by the latest quarter end. A fiscal-year tag such as FY2025 means only annual figures were available. Lower leaves more cushion; above 100% means paying out more than the company earned. It shows n/a for funds and when net income over the period was negative; for REITs and BDCs it is marked EPS-based, since they are judged on FFO/AFFO or net investment income instead.

Years Paying

15

How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.

Price / Book (TTM)

1.86

Price as of Oct 25, 2026; latest reported book value

Price-to-book ratio: the share price on the date shown divided by the latest reported book value per share. A rough valuation gauge, most useful for asset-heavy sectors like REITs, banks and insurers.

S.A.F.E. Dividend Read

S.A.F.E. is a set of four checks on a dividend's record and the company's data, the same test used across the screener and our ranked lists. Solid: a Dividend Safety Score of 70+ and a yield of 2%+. Accelerating: at least three consecutive completed calendar years of higher total regular dividends. Flawless: since 1990, no calendar year whose total regular dividend fell more than 20% below the year before, and no suspension. Enduring: at least 20 years between the first and latest dividend in our records. All four met earns the S.A.F.E. flag.
S Solid
Meets the Solid check: Dividend Safety Score 92/100 and yield 2.11%.
A Accelerating
Dividend growth has stalled — 0 consecutive annual increase(s), under the 3 this check looks for.
F Flawless
A calendar year's regular dividend total fell more than 20% below the year before.
E Enduring
15 year(s) of payments on record, under the 20 this check looks for.

Quote & Key Data

ExchangeOther OTCThe stock exchange where the shares trade, such as NYSE or Nasdaq.
Volume241Oct 23, 2026 sessionHow many shares changed hands in the trading session dated beside this figure, a rough read on trading activity. Daily bars are refreshed on a slower cycle than the quoted price, so this session can be older than the price above.
Open$11.19Oct 23, 2026 sessionThe price at the start of the trading session dated beside this figure, which can be earlier than the session the quoted price comes from.
Day Range$11.19 – $11.19Oct 23, 2026 sessionThe lowest and highest price during the trading session dated beside this figure, which can be earlier than the session the quoted price comes from.
Prev Close$11.03Close of Oct 22, 2026The closing price from the session before the one dated beside these figures.
Market Cap$3.46BAs of Oct 30, 2026The company's total market value (share price times shares outstanding) on the date shown.
Shares Out321.28MImplied by market cap, Oct 30, 2026Shares outstanding implied by the market cap and share price on the date shown.
EPS (TTM)JPY 120.3612 months to Jun 30, 2026 (Q1 FY2027); reported in JPYEarnings per share over the trailing twelve months (TTM), labeled with the end date of the latest reported quarter and shown in the company's reporting currency. Dividends are paid out of these earnings.
P/E (TTM)14.6Price as of Oct 25, 2026; earnings to Jun 30, 2026Price-to-earnings ratio: the share price on the date shown divided by trailing-twelve-month earnings per share. A rough gauge of how richly the stock is valued.
Last Ex-DateSep 29, 2026Pays Nov 30, 2026The most recent ex-dividend date that has already passed.
Next Ex-DateN/ANone declared yetThe ex-dividend date of the next payment the company has declared, or that is scheduled when no declaration is on file. Future dates our data provider only projects are not shown.

Dividend Growth

3-Yr Growth (CAGR)2.6%Annual totals, 2022–2025The dividend's average annual growth rate over the period, compounded.
5-Yr Growth (CAGR)-1.0%Annual totals, 2020–2025The dividend's average annual growth rate over the period, compounded.
Consecutive Increases0 yrsAnnual totals through 2025The number of consecutive years the dividend has increased.

Why the Yield Moved (90 Days)

SNPHY's dividend yield rose from 2.10% to 2.11% over the past ~90 days (+0.01 pp). Of that move, -0.11 pp came from changes in the dividend rate and +0.12 pp from the share price ($11.39 on Aug 03, 2026 → $10.78 on Oct 30, 2026). A yield that rises because the price fell is not an improvement in the payout itself.

Yield vs Its Own History

Current2.11%
1-Yr Average2.26%
Low / High1.72% – 3.41%
Percentile33%

Across 272 daily observations over the past 13 months (through Oct 23, 2026), SNPHY's current yield is higher than approximately 33% of them. Our stored price history for SNPHY covers the past 13 months; 3- and 5-year averages are not yet computable from it and are deliberately not shown.

Adjusted Price History

Dividend History

Dividend Payment History

Ex-dividend calendar →
Amount Type Declared Ex-Date Record Pay
$0.1098 S Regular N/A Sep 29, 2026 Sep 30, 2026 Nov 30, 2026
$0.1172 S Regular Mar 03, 2026 Mar 31, 2026 Mar 31, 2026 Jul 14, 2026
$0.1215 Q Regular Sep 03, 2025 Sep 30, 2025 Sep 30, 2025 Dec 08, 2025
$0.1301 S Regular Mar 05, 2025 Mar 31, 2025 Mar 31, 2025 Jul 10, 2025
$0.1131 S Regular Sep 09, 2024 Sep 30, 2024 Sep 30, 2024 Dec 16, 2024
$0.1057 S Regular Mar 04, 2024 Mar 28, 2024 Mar 28, 2024 Jul 11, 2024
$0.1076 S Regular Sep 06, 2023 Sep 29, 2023 Sep 29, 2023 Dec 15, 2023
$0.1106 S Regular Feb 21, 2023 Mar 31, 2023 Mar 31, 2023 Jul 13, 2023
$0.1149 S Regular Aug 22, 2022 Sep 30, 2022 Sep 30, 2022 Dec 15, 2022
$0.1181 S Regular Feb 25, 2022 Mar 30, 2022 Mar 30, 2022 Jul 12, 2022
$0.1414 S Regular N/A Sep 29, 2021 Sep 29, 2021 Dec 15, 2021
$0.1262 S Regular N/A Mar 30, 2021 Mar 30, 2021 Jul 13, 2021
$0.1343 S Regular Sep 30, 2020 Sep 29, 2020 Sep 29, 2020 Dec 15, 2020
$0.1304 S Regular Mar 04, 2020 Mar 30, 2020 Mar 30, 2020 Jul 10, 2020
$0.1186 S Regular N/A Sep 27, 2019 Sep 27, 2019 Dec 16, 2019
$0.1206 S Regular Mar 06, 2019 Mar 29, 2019 Mar 29, 2019 Jul 11, 2019
$0.1144 S Regular Sep 06, 2018 Sep 26, 2018 Sep 28, 2018 Dec 17, 2018
$0.1178 S Regular Mar 02, 2018 Mar 27, 2018 Mar 29, 2018 Jul 12, 2018
$0.1157 S Regular Sep 11, 2017 Sep 27, 2017 Sep 30, 2017 Nov 01, 2017
$0.1165 S Regular Mar 02, 2017 Mar 28, 2017 Mar 30, 2017 Jul 11, 2017
$0.1143 S Regular Sep 08, 2016 Sep 28, 2016 Sep 29, 2016 Dec 15, 2016
$0.1275 S Regular Mar 03, 2016 Mar 29, 2016 Mar 30, 2016 Jul 12, 2016
$0.0975 S Regular N/A Sep 28, 2015 Sep 29, 2015 Dec 15, 2015
$0.2422 S Regular N/A Mar 29, 2015 Mar 30, 2015 Jul 10, 2015
$0.2105 S Regular N/A Sep 28, 2014 Sep 29, 2014 Dec 15, 2014
$0.2455 S Regular N/A Mar 27, 2014 Mar 28, 2014 Jul 11, 2014
$0.2439 S Regular N/A Sep 26, 2013 Sep 27, 2013 Dec 16, 2013
$0.2549 S Regular N/A Mar 27, 2013 Mar 28, 2013 Jul 11, 2013
$0.3024 S Regular N/A Sep 26, 2012 Sep 27, 2012 Dec 17, 2012
$0.3116 S Regular N/A Mar 28, 2012 Mar 29, 2012 Jul 06, 2012
$0.3200 S Regular N/A Sep 28, 2011 Sep 29, 2011 Dec 15, 2011

Peer Comparison

Selected Drug Manufacturers - General dividend payers we cover, strongest DividendRank first — for context, not a recommendation.

TickerNameYield5-Yr GrowthStreakRank
ZTS Zoetis Inc. 2.69% 20.1% 11 yrs 94
BMY Bristol-Myers Squibb Company 4.10% 6.6% 18 yrs 86
ALPMY Astellas Pharma Inc. 3.10% 5.6% 11 yrs 80
ALPMF Astellas Pharma Inc. 2.87% 5.9% 3 yrs 80

Related Guides & Lists

SNPHY dividend — frequently asked questions

Does Santen Pharmaceutical Co., Ltd. pay a dividend?

Yes. Santen Pharmaceutical Co., Ltd. (SNPHY) currently pays a dividend. The annualized dividend is about $0.23 per share, a yield of approximately 2.11%.

What is Santen Pharmaceutical Co., Ltd.'s dividend yield?

Santen Pharmaceutical Co., Ltd.'s dividend yield is approximately 2.11%, based on the most recent regular payment annualized against the current share price. Yields move as the share price changes.

How often does Santen Pharmaceutical Co., Ltd. pay dividends?

Santen Pharmaceutical Co., Ltd. pays dividends semi-annually — 2 times per year.

How long has Santen Pharmaceutical Co., Ltd. paid dividends?

Santen Pharmaceutical Co., Ltd. has 15 years of dividend payments on record.

Data updated Oct 30, 2026. This research page is generated from Dividendly's structured market and dividend dataset using the approach described on our methodology and data sources pages. Data is automatically validated using defined rules and may also be periodically reviewed. Research only, not investment advice. Spotted a data error? Report it.